位置:首页 > 蛋白库 > NPHN_MOUSE
NPHN_MOUSE
ID   NPHN_MOUSE              Reviewed;        1256 AA.
AC   Q9QZS7; D2KXA7; Q811S5; Q925S5; Q9ESC6; Q9ET59; Q9JIX1;
DT   16-APR-2002, integrated into UniProtKB/Swiss-Prot.
DT   08-MAR-2011, sequence version 2.
DT   03-AUG-2022, entry version 170.
DE   RecName: Full=Nephrin;
DE   AltName: Full=Renal glomerulus-specific cell adhesion receptor;
DE   Flags: Precursor;
GN   Name=Nphs1; Synonyms=Nphn;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RX   PubMed=10504499; DOI=10.1046/j.1523-1755.1999.00719.x;
RA   Holzman L.B., St John P.L., Kovari I.A., Verma R., Holthoefer H.,
RA   Abrahamson D.R.;
RT   "Nephrin localizes to the slit pore of the glomerular epithelial cell.";
RL   Kidney Int. 56:1481-1491(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=10820162; DOI=10.1681/asn.v116991;
RA   Putaala H., Sainio K., Sariola H., Tryggvason K.;
RT   "Primary structure of mouse and rat nephrin cDNA and structure and
RT   expression of the mouse gene.";
RL   J. Am. Soc. Nephrol. 11:991-1001(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE [GENOMIC DNA]
RP   OF 1-494 (ISOFORM 1), FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=129/SvEv, and C57BL/6J;
RX   PubMed=12039968; DOI=10.1074/jbc.m204806200;
RA   Hamano Y., Grunkemeyer J.A., Sudhakar A., Zeisberg M., Cosgrove D.,
RA   Morello R., Lee B., Sugimoto H., Kalluri R.;
RT   "Determinants of vascular permeability in the kidney glomerulus.";
RL   J. Biol. Chem. 277:31154-31162(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SELF-ASSOCIATION, INTERACTION WITH
RP   KIRREL2, AND TISSUE SPECIFICITY.
RX   PubMed=19887377; DOI=10.1074/jbc.m109.060657;
RA   Nishida K., Hoshino M., Kawaguchi Y., Murakami F.;
RT   "Ptf1a directly controls expression of immunoglobulin superfamily molecules
RT   Nephrin and Neph3 in the developing central nervous system.";
RL   J. Biol. Chem. 285:373-380(2010).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-19 (ISOFORM 2), TISSUE SPECIFICITY,
RP   AND ALTERNATIVE SPLICING.
RC   STRAIN=129/Sv;
RX   PubMed=12538735; DOI=10.1097/01.asn.0000043081.65110.c4;
RA   Beltcheva O., Kontusaari S., Fetissov S., Putaala H., Kilpelainen P.,
RA   Hokfelt T., Tryggvason K.;
RT   "Alternatively used promoters and distinct elements direct tissue-specific
RT   expression of nephrin.";
RL   J. Am. Soc. Nephrol. 14:352-358(2003).
RN   [7]
RP   INTERACTION WITH CD2AP.
RX   PubMed=11733379; DOI=10.1016/s0002-9440(10)63080-5;
RA   Shih N.Y., Li J., Cotran R., Mundel P., Miner J.H., Shaw A.S.;
RT   "CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-
RT   terminal domain.";
RL   Am. J. Pathol. 159:2303-2308(2001).
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=11136707; DOI=10.1093/hmg/10.1.1;
RA   Putaala H., Soininen R., Kilpelainen P., Wartiovaara J., Tryggvason K.;
RT   "The murine nephrin gene is specifically expressed in kidney, brain and
RT   pancreas: inactivation of the gene leads to massive proteinuria and
RT   neonatal death.";
RL   Hum. Mol. Genet. 10:1-8(2001).
RN   [9]
RP   INTERACTION WITH CD2AP AND NPHS2.
RX   PubMed=11733557; DOI=10.1172/jci200112849;
RA   Schwarz K., Simons M., Reiser J., Saleem M.A., Faul C., Kriz W., Shaw A.S.,
RA   Holzman L.B., Mundel P.;
RT   "Podocin, a raft-associated component of the glomerular slit diaphragm,
RT   interacts with CD2AP and nephrin.";
RL   J. Clin. Invest. 108:1621-1629(2001).
RN   [10]
RP   INTERACTION WITH KIRREL1.
RC   STRAIN=Swiss Webster; TISSUE=Brain;
RX   PubMed=12424224; DOI=10.1096/fj.02-0242fje;
RA   Sellin L., Huber T.B., Gerke P., Quack I., Pavenstaedt H., Walz G.;
RT   "NEPH1 defines a novel family of podocin interacting proteins.";
RL   FASEB J. 17:115-117(2003).
RN   [11]
RP   SELF-ASSOCIATION, AND INTERACTION WITH KIRREL1.
RX   PubMed=12660326; DOI=10.1097/01.asn.0000057853.05686.89;
RA   Gerke P., Huber T.B., Sellin L., Benzing T., Walz G.;
RT   "Homodimerization and heterodimerization of the glomerular podocyte
RT   proteins nephrin and NEPH1.";
RL   J. Am. Soc. Nephrol. 14:918-926(2003).
RN   [12]
RP   INTERACTION WITH KIRREL3.
RX   PubMed=15843475; DOI=10.1681/asn.2004060439;
RA   Gerke P., Sellin L., Kretz O., Petraschka D., Zentgraf H., Benzing T.,
RA   Walz G.;
RT   "NEPH2 is located at the glomerular slit diaphragm, interacts with nephrin
RT   and is cleaved from podocytes by metalloproteinases.";
RL   J. Am. Soc. Nephrol. 16:1693-1702(2005).
RN   [13]
RP   INTERACTION WITH DDN.
RX   PubMed=17537921; DOI=10.1073/pnas.0700917104;
RA   Asanuma K., Campbell K.N., Kim K., Faul C., Mundel P.;
RT   "Nuclear relocation of the nephrin and CD2AP-binding protein dendrin
RT   promotes apoptosis of podocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:10134-10139(2007).
RN   [14]
RP   INTERACTION WITH KIRREL3.
RX   PubMed=18752272; DOI=10.1002/cne.21838;
RA   Komori T., Gyobu H., Ueno H., Kitamura T., Senba E., Morikawa Y.;
RT   "Expression of kin of irregular chiasm-like 3/mKirre in proprioceptive
RT   neurons of the dorsal root ganglia and its interaction with nephrin in
RT   muscle spindles.";
RL   J. Comp. Neurol. 511:92-108(2008).
RN   [15]
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=19470472; DOI=10.1073/pnas.0904398106;
RA   Sohn R.L., Huang P., Kawahara G., Mitchell M., Guyon J., Kalluri R.,
RA   Kunkel L.M., Gussoni E.;
RT   "A role for nephrin, a renal protein, in vertebrate skeletal muscle cell
RT   fusion.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:9274-9279(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Seems to play a role in the development or function of the
CC       kidney glomerular filtration barrier. Regulates glomerular vascular
CC       permeability. May anchor the podocyte slit diaphragm to the actin
CC       cytoskeleton. Plays a role in skeletal muscle formation through
CC       regulation of myoblast fusion. {ECO:0000269|PubMed:11136707,
CC       ECO:0000269|PubMed:12039968, ECO:0000269|PubMed:19470472}.
CC   -!- SUBUNIT: Interacts with NPHS2 and with CD2AP (via C-terminal domain).
CC       Interacts with MAGI1 (via PDZ 2 and 3 domains) forming a tripartite
CC       complex with IGSF5/JAM4. Forms a complex with ACTN4, CASK, IQGAP1,
CC       MAGI2, SPTAN1 and SPTBN1 (By similarity). Interacts with DDN; the
CC       interaction is direct. Self-associates (via the Ig-like domains). Also
CC       interacts (via the Ig-like domains) with KIRREL1 and KIRREL2; the
CC       interaction with KIRREL1 is dependent on KIRREL1 glycosylation.
CC       Interacts with KIRREL3 (PubMed:15843475, PubMed:18752272).
CC       {ECO:0000250|UniProtKB:Q9R044, ECO:0000269|PubMed:11733379,
CC       ECO:0000269|PubMed:11733557, ECO:0000269|PubMed:12424224,
CC       ECO:0000269|PubMed:12660326, ECO:0000269|PubMed:15843475,
CC       ECO:0000269|PubMed:17537921, ECO:0000269|PubMed:18752272,
CC       ECO:0000269|PubMed:19887377}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}. Note=Located at podocyte slit diaphragm
CC       between podocyte foot processes. {ECO:0000269|PubMed:10504499}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=NephrinA;
CC         IsoId=Q9QZS7-1; Sequence=Displayed;
CC       Name=2; Synonyms=NephrinB;
CC         IsoId=Q9QZS7-2; Sequence=VSP_040676;
CC   -!- TISSUE SPECIFICITY: Expressed in kidney glomeruli. In the embryo,
CC       expressed in the mesonephric kidney at 11 dpc with strong expression in
CC       cranial tubules with podocyte-like structures. Expression is observed
CC       in the podocytes of the developing kidney from 13 dpc. High expression
CC       is also detected in the developing cerebellum, hindbrain, spinal cord,
CC       retina and hypothalamus. Expressed in skeletal muscle during myoblast
CC       fusion such as in the adult following acute injury and in the embryo
CC       but not detected in uninjured adult skeletal muscle. Isoform 1 and
CC       isoform 2 are expressed in the newborn brain and developing cerebellum.
CC       Isoform 1 is the predominant isoform in adult kidney.
CC       {ECO:0000269|PubMed:10820162, ECO:0000269|PubMed:11136707,
CC       ECO:0000269|PubMed:12538735, ECO:0000269|PubMed:19470472,
CC       ECO:0000269|PubMed:19887377}.
CC   -!- PTM: Phosphorylated at Tyr-1208 by FYN, leading to the recruitment and
CC       activation of phospholipase C-gamma-1/PLCG1. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Death by postnatal day 2 associated with
CC       proteinuria, edema and massive glomerular vascular leak. Kidneys
CC       display enlarged Bowman's spaces, dilated tubuli, effacement of
CC       podocyte foot processes and an absence of the glomerular epithelial
CC       slit diaphragm. Impaired skeletal muscle development characterized by
CC       incomplete myoblast fusion. {ECO:0000269|PubMed:11136707,
CC       ECO:0000269|PubMed:12039968, ECO:0000269|PubMed:19470472}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF168466; AAF03368.1; -; mRNA.
DR   EMBL; AF172254; AAF91085.1; -; Genomic_DNA.
DR   EMBL; AF172247; AAF91085.1; JOINED; Genomic_DNA.
DR   EMBL; AF172248; AAF91085.1; JOINED; Genomic_DNA.
DR   EMBL; AF172249; AAF91085.1; JOINED; Genomic_DNA.
DR   EMBL; AF172250; AAF91085.1; JOINED; Genomic_DNA.
DR   EMBL; AF172251; AAF91085.1; JOINED; Genomic_DNA.
DR   EMBL; AF172252; AAF91085.1; JOINED; Genomic_DNA.
DR   EMBL; AF172253; AAF91085.1; JOINED; Genomic_DNA.
DR   EMBL; AF172256; AAF91087.1; -; mRNA.
DR   EMBL; AF190638; AAG17142.1; -; Genomic_DNA.
DR   EMBL; AF191090; AAK38483.1; -; mRNA.
DR   EMBL; AB513652; BAI63574.1; -; mRNA.
DR   EMBL; AC167970; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AY183460; AAO22850.1; -; Genomic_DNA.
DR   CCDS; CCDS39884.1; -. [Q9QZS7-1]
DR   RefSeq; NP_062332.2; NM_019459.2. [Q9QZS7-1]
DR   RefSeq; XP_011248949.1; XM_011250647.1. [Q9QZS7-2]
DR   AlphaFoldDB; Q9QZS7; -.
DR   BioGRID; 207694; 5.
DR   DIP; DIP-61265N; -.
DR   IntAct; Q9QZS7; 3.
DR   STRING; 10090.ENSMUSP00000006825; -.
DR   GlyGen; Q9QZS7; 7 sites.
DR   iPTMnet; Q9QZS7; -.
DR   PhosphoSitePlus; Q9QZS7; -.
DR   jPOST; Q9QZS7; -.
DR   PaxDb; Q9QZS7; -.
DR   PRIDE; Q9QZS7; -.
DR   ProteomicsDB; 293879; -. [Q9QZS7-1]
DR   ProteomicsDB; 293880; -. [Q9QZS7-2]
DR   Antibodypedia; 29541; 780 antibodies from 40 providers.
DR   DNASU; 54631; -.
DR   Ensembl; ENSMUST00000006825; ENSMUSP00000006825; ENSMUSG00000006649. [Q9QZS7-1]
DR   Ensembl; ENSMUST00000126297; ENSMUSP00000116500; ENSMUSG00000006649. [Q9QZS7-2]
DR   GeneID; 54631; -.
DR   KEGG; mmu:54631; -.
DR   UCSC; uc009gem.1; mouse. [Q9QZS7-2]
DR   UCSC; uc009gen.1; mouse. [Q9QZS7-1]
DR   CTD; 4868; -.
DR   MGI; MGI:1859637; Nphs1.
DR   VEuPathDB; HostDB:ENSMUSG00000006649; -.
DR   eggNOG; KOG3515; Eukaryota.
DR   GeneTree; ENSGT00940000159510; -.
DR   HOGENOM; CLU_003881_0_1_1; -.
DR   InParanoid; Q9QZS7; -.
DR   OMA; CEVSNIM; -.
DR   OrthoDB; 269917at2759; -.
DR   PhylomeDB; Q9QZS7; -.
DR   TreeFam; TF327139; -.
DR   Reactome; R-MMU-373753; Nephrin family interactions.
DR   BioGRID-ORCS; 54631; 2 hits in 73 CRISPR screens.
DR   ChiTaRS; Nphs1; mouse.
DR   PRO; PR:Q9QZS7; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   RNAct; Q9QZS7; protein.
DR   Bgee; ENSMUSG00000006649; Expressed in renal glomerulus and 58 other tissues.
DR   ExpressionAtlas; Q9QZS7; baseline and differential.
DR   Genevisible; Q9QZS7; MM.
DR   GO; GO:0005604; C:basement membrane; ISO:MGI.
DR   GO; GO:0042995; C:cell projection; IDA:UniProtKB.
DR   GO; GO:0005911; C:cell-cell junction; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005925; C:focal adhesion; IDA:MGI.
DR   GO; GO:0016021; C:integral component of membrane; TAS:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; ISO:MGI.
DR   GO; GO:0045121; C:membrane raft; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0032991; C:protein-containing complex; ISO:MGI.
DR   GO; GO:0036057; C:slit diaphragm; ISS:UniProtKB.
DR   GO; GO:0051393; F:alpha-actinin binding; ISO:MGI.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IBA:GO_Central.
DR   GO; GO:0017022; F:myosin binding; ISO:MGI.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:MGI.
DR   GO; GO:0030507; F:spectrin binding; ISO:MGI.
DR   GO; GO:0007155; P:cell adhesion; IGI:MGI.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0032836; P:glomerular basement membrane development; IEA:Ensembl.
DR   GO; GO:0007254; P:JNK cascade; IDA:MGI.
DR   GO; GO:0000165; P:MAPK cascade; IDA:MGI.
DR   GO; GO:0007520; P:myoblast fusion; IMP:UniProtKB.
DR   GO; GO:0072015; P:podocyte development; IEA:Ensembl.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; IGI:MGI.
DR   GO; GO:0035418; P:protein localization to synapse; ISO:MGI.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IMP:UniProtKB.
DR   GO; GO:0036060; P:slit diaphragm assembly; IMP:UniProtKB.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; -; 10.
DR   InterPro; IPR013162; CD80_C2-set.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   Pfam; PF08205; C2-set_2; 5.
DR   Pfam; PF00041; fn3; 1.
DR   SMART; SM00060; FN3; 1.
DR   SMART; SM00409; IG; 8.
DR   SMART; SM00408; IGc2; 6.
DR   SUPFAM; SSF48726; SSF48726; 9.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS50835; IG_LIKE; 8.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell membrane; Developmental protein;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Membrane; Myogenesis;
KW   Phosphoprotein; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..35
FT                   /evidence="ECO:0000255"
FT   CHAIN           36..1256
FT                   /note="Nephrin"
FT                   /id="PRO_0000015053"
FT   TOPO_DOM        36..1078
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1079..1099
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1100..1256
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          39..144
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          149..247
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          256..347
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          354..448
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          454..554
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          558..649
FT                   /note="Ig-like C2-type 6"
FT   DOMAIN          754..846
FT                   /note="Ig-like C2-type 7"
FT   DOMAIN          852..953
FT                   /note="Ig-like C2-type 8"
FT   DOMAIN          957..1051
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          491..516
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1048..1071
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1112..1143
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1112..1136
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         446
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O60500"
FT   MOD_RES         1112
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R044"
FT   MOD_RES         1115
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R044"
FT   MOD_RES         1119
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R044"
FT   MOD_RES         1208
FT                   /note="Phosphotyrosine; by FYN"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R044"
FT   CARBOHYD        54
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        370
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        415
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        561
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        578
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        591
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        722
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        67..125
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        174..231
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        279..331
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        375..431
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        479..542
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        581..637
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        775..830
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        877..934
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1..33
FT                   /note="MGAKEATVRGPGASPVHRTCHLIPLLLAGMLTT -> MEKWRAWDPQSIQRR
FT                   KTAK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:19887377"
FT                   /id="VSP_040676"
FT   CONFLICT        1..24
FT                   /note="MGAKEATVRGPGASPVHRTCHLIP -> MALGTTLRAS (in Ref. 1;
FT                   AAF03368)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        6
FT                   /note="A -> V (in Ref. 2; AAF91087)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        21
FT                   /note="H -> R (in Ref. 2; AAF91087)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        43
FT                   /note="S -> P (in Ref. 2; AAF91085, 3; AAG17142/AAK38483
FT                   and 4; BAI63574)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        63
FT                   /note="V -> I (in Ref. 1; AAF03368 and 2; AAF91087)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        140
FT                   /note="S -> R (in Ref. 1; AAF03368 and 2; AAF91087)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        145
FT                   /note="I -> V (in Ref. 1; AAF03368 and 2; AAF91087)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        148
FT                   /note="S -> P (in Ref. 1; AAF03368 and 2; AAF91087)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        178
FT                   /note="D -> G (in Ref. 1; AAF03368 and 2; AAF91087)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        763
FT                   /note="T -> A (in Ref. 1; AAF03368)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        996
FT                   /note="S -> T (in Ref. 1; AAF03368 and 2; AAF91087)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1076
FT                   /note="L -> Q (in Ref. 1; AAF03368)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1256 AA;  136336 MW;  339A670F2AF000A2 CRC64;
     MGAKEATVRG PGASPVHRTC HLIPLLLAGM LTTGLAQSPV PTSAPRGFWA LSENLTVVEG
     STVKLWCGVR APGSVVQWAK DGLLLGPNPK IPGFPRYSLE GDSAKGEFHL LIEACDLSDD
     AEYECQVGRS ELGPELVSPS VILSILVSPK VLQLTPEAGS TVTWVAGQEY VVTCVSGDAK
     PAPDIIFIQG GRTVEDVSSS VNEGSEEKLF FTEAEARVTP QSSDNGQLLV CEGSNPALAT
     PIKASFTMNI LFPPGPPVID WPGLNEGHVR AGENLELPCI ARGGNPPATL QWLKNGKPVS
     IAWGTEHAQA VAHSVLVMTV RPEDHGARLS CQSYNSVSAE TQERSITLQV TFPPSAVTIL
     GSTSQSENKN VTLCCLTKSS RPRVLLRWWL GGRQLLPTDE TVMDGLHGGH ISMSNLTLLV
     KREDNGLSLT CEAFSDAFSK ETFKKSLTLN VKYPAQKLWI EGPPEGQSIR TGTRVRLVCL
     AIGGNPEPSL TWLKDSRPVN DPRQSQEPRR VQLGSVEKSG STFSRELVLI IGPPDNLAKF
     SCKAGQLSAS TQLVVQFPPT NLTILANSSA LRPGDALNLT CVSISSNPPV NLSLDKEGER
     LDDVAAKPQS APFKGSAASR SVFLRVSSRD HGHRVTCRAH SEALRETVSS FYRLNVLYPP
     EFLGEQVRAV TVVEQGQALL PVSVSANPAP EAFNWTFRGY RLSPAGGPRH RILSGGALQL
     WNVTRADDGF YQLHCQNSEG TAEALLKLDV HYAPTIRALK DPTEVNVGGS VDIVCTVDAN
     PILPEMFSWE RLGEDEEELN LDDMEKMSKG STGRLRIRQA KLSQAGAYQC IVDNGVAPAA
     RGLVRLVVRF APQVDHPTPL TKVAAAGDST SSATLHCRAR GVPNIDFTWT KNGVPLDLQD
     PRYTEHKYHQ GVVHSSLLTI ANVSAAQDYA LFKCTATNAL GSDHTNIQLV SISRPDPPLG
     LKVVSVSPHS VGLEWKPGFD GGLPQRFQIR YEALESPGFL YMDVLPAQAT TFTLTGLKPS
     TRYRIWLLAS NALGDSGLTD KGIQVSITTP GLDQAPEDTD QPLPTEQPPG PPRLPLLPVL
     FAVGGLLLLS NASCVGGLLW RRRLRRLAEE ISEKTEAGSE EDRIRNEYEE SQWTGDRDTR
     SSTVSTAEVD PHYYSMRDFS PQLPPTLEEV SYRQAFTGIE DEDMAFPGHL YDEVERVYGP
     PGVWGPLYDE VQMDPYDLRW PEVKYEDPRG IYDQVAADMD AGEPGSLPFE LRGHLV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024